Recent alcohol use is associated with increased Pre-exposure Prophylaxis (PrEP) continuation and adherence among pregnant and post-partum women in South Africa
Human Science Research Council SA · 2026-05-22
DOI: 10.14749/32364048 ↗At a glance
Journal article in Human Science Research Council SA, published on 2026-05-22. Written by Human Sciences Research Council.
Abstract (original language)
Background
South African women experience high levels of alcohol use and HIV infection during the perinatal period. Oral pre-exposure prophylaxis (PrEP) is highly effective at reducing HIV risk. We examined associations between alcohol use and PrEP use during pregnancy and postpartum.
Methods
PrEP-PP is a prospective observational cohort of 1200 HIV-negative pregnant women enrolled at first antenatal care visit and followed through 12 months postpartum in Cape Town, South Africa. The analytic sample comprised pregnant women who initiated PrEP at baseline and were not censored from study follow-up prior to 3 month follow-up. We examined associations between any or hazardous alcohol use (AUDIT-C score ->3) in the year prior to pregnancy and PrEP continuation and adherence during pregnancy (self-report of missing
Subjects
Cite
APA
Council, H. S. R. (2026). Recent alcohol use is associated with increased Pre-exposure Prophylaxis (PrEP) continuation and adherence among pregnant and post-partum women in South Africa. Human Science Research Council SA. https://doi.org/10.14749/32364048
Vancouver
Council HSR. Recent alcohol use is associated with increased Pre-exposure Prophylaxis (PrEP) continuation and adherence among pregnant and post-partum women in South Africa. Human Science Research Council SA. 2026. doi:10.14749/32364048
BibTeX
@article{Council2026,
author = {Council, Human Sciences Research},
title = {Recent alcohol use is associated with increased Pre-exposure Prophylaxis (PrEP) continuation and adherence among pregnant and post-partum women in South Africa},
journal = {Human Science Research Council SA},
year = {2026},
doi = {10.14749/32364048}
}
EUVIMED